Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
7.64
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $17.86 million as of January 23, 2026. Its market cap has decreased by -38.74% in one year.
Market Cap
17.86M
Enterprise Value
14.00M
1-Year Change
-38.74%
Ranking
Category
Stock Price
$7.64
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $17.86M, a decrease of -69.29%. That is a compound annual growth rate of -32.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 17.86M | 12.68% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 19.10M |
| Lisata Therapeutics | 19.05M |
| CollPlant Biotechnologies | 18.78M |
| OSR Holdings | 18.45M |
| Lexaria Bioscience | 18.31M |
| Kairos Pharma | 18.21M |
| ProMIS Neurosciences | 17.57M |
| Iterum Therapeutics | 17.40M |